Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Prognostic Impact of N2 of the Primary Tumour in Surgical Resection for Colorectal Liver Metastases

KOICHI TOMITA, NAOKAZU CHIBA, SHIGETO OCHIAI, TAKAHIRO GUNJI, TOSHIMICHI KOBAYASHI, TORU SANO, EIJI HIDAKA and SHIGEYUKI KAWACHI
Anticancer Research April 2022, 42 (4) 1997-2001; DOI: https://doi.org/10.21873/anticanres.15678
KOICHI TOMITA
Department of Digestive and Transplantation Surgery, Tokyo Medical University Hachioji Medical Center, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NAOKAZU CHIBA
Department of Digestive and Transplantation Surgery, Tokyo Medical University Hachioji Medical Center, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHIGETO OCHIAI
Department of Digestive and Transplantation Surgery, Tokyo Medical University Hachioji Medical Center, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAKAHIRO GUNJI
Department of Digestive and Transplantation Surgery, Tokyo Medical University Hachioji Medical Center, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TOSHIMICHI KOBAYASHI
Department of Digestive and Transplantation Surgery, Tokyo Medical University Hachioji Medical Center, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TORU SANO
Department of Digestive and Transplantation Surgery, Tokyo Medical University Hachioji Medical Center, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
EIJI HIDAKA
Department of Digestive and Transplantation Surgery, Tokyo Medical University Hachioji Medical Center, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHIGEYUKI KAWACHI
Department of Digestive and Transplantation Surgery, Tokyo Medical University Hachioji Medical Center, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: skawachi@tokyo-med.ac.jp
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background/Aim: The status of lymph node metastasis of primary tumours remains to be completely investigated. This study investigated the prognostic impact of the degree of primary lymph node metastasis in patients with colorectal liver metastasis. Patients and Methods: We retrospectively analysed the clinical data of 106 patients with colorectal liver metastases who underwent surgical resection. Prognostic factors, including the degree of the positive primary lymph nodes, positive lymph node ratio, and log odds of positive lymph nodes, were evaluated. Results: The T factor and N2 status were independent risk factors for overall survival in patients who underwent surgical resection. Survival was significantly lower in the N2 group than in the N0-1 group. Additionally, ≥N2 status showed better prognostic performance than ≥N1 status. Conclusion: N2 of primary tumours is an independent useful prognostic factor in colorectal liver metastasis and can help determine the indication of surgical resection and pre/post-operative chemotherapy.

Key Words:
  • Colorectal liver metastasis
  • prognostic factor
  • lymph node metastasis
  • N factor
  • TNM classification

Previously, synchronous metastases, primary lymph node metastasis, number of tumours, extrahepatic metastasis at hepatectomy, and preoperative tumour marker levels were reported as prognostic factors for colorectal liver metastasis (1). Of these factors, the status of lymph node metastasis of the primary tumour remains to be completely investigated in terms of its prognostic impact. For example, the clinical risk score reported by Fong et al. is a well-known risk index for surgical resection of colorectal liver metastasis (2). According to this risk score, the lymph node of the primary tumour was evaluated as positive or negative only. Other prognostic indices or risk indices also evaluated the lymph node of the primary tumour in the same manner (3). However, the correlation between the degree of primary lymph node metastasis and the prognosis of patients with liver metastasis has not been well investigated.

Therefore, this study investigated the detailed prognostic value of lymph node metastasis in primary colorectal tumours to strengthen the accuracy of prognosis prediction, enhance our understanding of the indications for pre- and postoperative treatment, and potentially improve the outcomes of patients with colorectal liver metastasis.

Patients and Methods

Subjects. Clinical data of 111 patients with colorectal liver metastasis who underwent surgical resection at the Tokyo Medical University Hachioji Medical Center between June 2007 and July 2020 were retrospectively analysed. Patients with extrahepatic metastasis to the lung, lymph nodes, and peritoneal dissemination (N=5) were excluded, leaving 106 patients included in the study. All patients underwent surgical resection for the primary tumour before or at the same time as surgery for liver metastasis. This helped prevent stenosis or bleeding due to the primary tumour.

Pathological definition of the primary tumour. The primary tumour was pathologically diagnosed based on the TNM classification system of the American Joint Committee on Cancer (AJCC)/Union for International Cancer Control (UICC) guidelines. The classification of lymph node metastasis in colorectal cancer was also determined based on these guidelines. All regional lymph nodes were dissected, regardless of the degree of tumour progression. The dissected lymph nodes were removed from the tumour specimen and classified according to the guidelines.

The lymph nodes of the primary tumour were also evaluated using positive lymph node ratio (LNR) and log odds of positive lymph nodes (LODDS). These were calculated as follows:

  • LNR=positive lymph node/dissected lymph node,

  • LODDS=log [(positive lymph node + 0.5)/(negative lymph node + 0.5)].

The LNR was classified according to a system proposed by Berger et al. (4) and Rosenberg et al. (5), as follows: Berger et al., LNR1<0.05, 0.05≤LNR2<0.19, 0.19≤LNR3<0.39, and 0.39≤ LNR4≤1.00; Rosenberg et al., LNR0=0.00, 0.01≤LNR1≤0.17, 0.18≤LNR2≤0.41, 0.42≤LNR3≤0.69, and LNR4≥0.70. The LODDS was classified according to the classification proposed by Wang et al. (6) and Persiani et al. (7) as follows: Wang et al., LODDS1<–2.2, –2.2≤LODDS2<–1.1, –1.1≤LODDS3<0.0, 0.0≤ LODDS4<1.1, and LODDS5≥1.1; Persiani et al., LODDS1 ≤–1.36, –1.36<LODDS2≤-0.53, and LODDS3 >–0.53.

Treatment strategy for liver metastasis. Surgical resection, with or without preoperative treatment, was performed primarily when the liver metastasis could be resected technically and oncologically. Preoperative treatment was performed in cases wherein the risk of recurrence was high, such as cases of multiple synchronous metastases or difficult resection based on technical or oncological aspects. The surgical procedure used was selected based on anatomical tumour factors. Percutaneous transhepatic portal vein embolization was performed preoperatively when required.

Comparison of overall survival between ≥N1 and ≥N2. Overall survival was compared between the ≥N1 and ≥N2 statuses of the TNM classification of the primary tumour; it was defined as the duration of survival from the beginning of treatment for liver metastasis to the last follow-up or death by any cause. The prognostic factors for overall survival were evaluated using univariate and multivariate analyses. Moreover, prognosis was compared among N0, N1, and N2 of the TNM classification of the primary tumour. Additionally, the prognostic performance of ≥N1 and ≥N2 for 1-, 3-, 5-, and 7-year survival groups was compared.

Statistical analyses. Continuous variables are expressed as median with range (minimum–maximum), and the Mann–Whitney U-test was used for between-group comparisons. Categorical variables are expressed as number (%) and compared using the chi-square test or Fisher’s exact test, as required. Univariate and multivariate analyses were performed using Cox proportional hazards regression analysis with forward selection of the likelihood ratio. The prognosis was evaluated using the Kaplan–Meier method, and statistical differences were evaluated using the log-rank test. All statistical analyses were performed using IBM SPSS Statistics, version 26.0 (IBM Corp., Armonk, NY, USA).

Ethical statements. The procedures followed were in accordance with the ethical standards of the institutional review board of the Tokyo Medical University (T2019-0149). Informed consent was obtained from all individual participants included in the study.

Results

Patient characteristics, including a comparison between N0-1 and N2 of the primary tumour, are shown in Table I. The number of dissected lymph nodes was significantly higher in the N2 group than in the N0-1 group (p=0.001). However, even in the N0-1 group, five or more lymph nodes were dissected in 69 (94.5%) patients and 10 or more lymph nodes were dissected in 47 (64.4%) patients.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table I.

Patient characteristics.

In the univariate analysis, the T factor of the TNM classification, ≥N2 status, LNR classification by Berger et al. and Rosenberg et al., LODDS classification by Wang et al. and Persiani et al., and preoperative levels of carcinoembryonic antigen (CEA) significantly differed (Table II). Multivariate analysis showed that the T factor and N2 status of the TNM classification were independent risk factors of overall survival after surgical resection for colorectal liver metastasis. When comparing prognoses associated with N0, N1, and N2 statuses of a primary tumour, the survival outcome of the N2 group was poorer than that of the other two groups (Figure 1). Comparing prognostic performance between ≥N1 and ≥N2 of the primary tumour, ≥N2 showed a better outcome than ≥N1 in all groups for 1- to 7-year survival (Table III). The positive predictive value, negative predictive value, and odds ratio were higher in ≥N2 than in ≥N1 in all 1- to 7-year survival groups. In addition, significant differences were found between ≥N2 and ≥N1 regarding 3-, 5-, and 7-year survival.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table II.

Univariate and multivariate analyses of clinicopathological factors for overall survival.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Comparison of prognosis among N0, N1, and N2 of the TNM classification of primary tumour. Statistical differences between each pair were as follows: N0-N1, p=0.908; N1-N2, p=0.007; and N0-N2, p=0.008.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table III.

Comparison of prognostic performance between ≥N1 and ≥N2 of the primary tumour.

Discussion

According to a previous report, the prognosis of patients with stage III colorectal cancer varied with the number of positive lymph nodes (8), which led to the differences between IIIA and IIIC stages in the AJCC/UICC classification. Thus, as the prognosis of advanced colorectal cancer without metastasis differs with the number of positive lymph nodes, the prognosis in patients with colorectal liver metastasis (stage IV) might also be affected by the number of positive lymph nodes of the primary tumour.

Several methods have been considered for evaluating lymph nodes, such as the number of positive lymph nodes, LNR, metastatic lymph node size, and tumour differentiation of metastatic lymph nodes. A previous study found that of these indexes, the LNR classification by Rosenberg et al. showed better predictive power than the others, especially when the number of dissected lymph nodes was inadequate. Moreover, they suggested that LODDS showed the best performance and remained unaffected by the number of dissected lymph nodes when analysed as a continuous variable. However, these analyses were concerned with the prognosis of the primary tumour, whereas in the present study, only N2 of the TNM classification between lymph node evaluations was found as an independent risk factor for prognosis of liver metastasis.

Herein, the appropriate cut-off value for the number of positive lymph nodes was between N1 and N2. Wang et al. also reported that a lower number of positive lymph nodes is associated with improved survival in patients with colorectal liver metastasis and that the hazard ratio differs between ≤3 and ≥4 of the number of positive lymph nodes (9). Thus, N2 is an effective prognostic marker in colorectal liver metastasis.

Limitations. This study has several limitations. First, it was performed at a single center and included a relatively small number of patients. Second, the disease and treatment course for colorectal liver metastasis was variable. For instance, patients had synchronous versus metachronous tumours, did and did not undergo preoperative treatment, and were treated with and without adjuvant chemotherapy. Therefore, further studies with a larger patient cohort and more uniform disease and treatment characteristics should be performed.

Conclusion

N2 of the primary tumour in the TNM classification is an independent and useful prognostic factor in surgical resection for colorectal liver metastasis. This index will improve outcomes in patients with colorectal liver metastasis.

Footnotes

  • Authors’ Contributions

    KT was involved in project development, data collection and analysis, and original manuscript writing. NC, SO, TG, TK, TS, and EH participated in data collection, critical revision, and final approval of the manuscript. SK was involved in supervision, data collection, critical revision, and final approval of the manuscript.

  • Conflicts of Interest

    The Authors report no proprietary or commercial interest in any product mentioned or concept discussed in this article.

  • Received January 4, 2022.
  • Revision received February 4, 2022.
  • Accepted February 21, 2022.
  • Copyright © 2022 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

References

  1. ↵
    1. Oki E,
    2. Ando K,
    3. Nakanishi R,
    4. Sugiyama M,
    5. Nakashima Y,
    6. Kubo N,
    7. Kudou K,
    8. Saeki H,
    9. Nozoe T,
    10. Emi Y and
    11. Maehara Y
    : Recent advances in treatment for colorectal liver metastasis. Ann Gastroenterol Surg 2(3): 167-175, 2018. PMID: 29863162. DOI: 10.1002/ags3.12071
    OpenUrlCrossRefPubMed
  2. ↵
    1. Fong Y,
    2. Fortner J,
    3. Sun RL,
    4. Brennan MF and
    5. Blumgart LH
    : Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230(3): 309-18; discussion 318-21, 1999. PMID: 10493478. DOI: 10.1097/00000658-199909000-00004
    OpenUrlCrossRefPubMed
  3. ↵
    1. Rees M,
    2. Tekkis PP,
    3. Welsh FK,
    4. O’Rourke T and
    5. John TG
    : Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg 247(1): 125-135, 2008. PMID: 18156932. DOI: 10.1097/SLA.0b013e31815aa2c2
    OpenUrlCrossRefPubMed
  4. ↵
    1. Berger AC,
    2. Sigurdson ER,
    3. LeVoyer T,
    4. Hanlon A,
    5. Mayer RJ,
    6. Macdonald JS,
    7. Catalano PJ and
    8. Haller DG
    : Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol 23(34): 8706-8712, 2005. PMID: 16314630. DOI: 10.1200/JCO.2005.02.8852
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Rosenberg R,
    2. Engel J,
    3. Bruns C,
    4. Heitland W,
    5. Hermes N,
    6. Jauch KW,
    7. Kopp R,
    8. Pütterich E,
    9. Ruppert R,
    10. Schuster T,
    11. Friess H and
    12. Hölzel D
    : The prognostic value of lymph node ratio in a population-based collective of colorectal cancer patients. Ann Surg 251(6): 1070-1078, 2010. PMID: 20485149. DOI: 10.1097/SLA.0b013e3181d7789d
    OpenUrlCrossRefPubMed
  6. ↵
    1. Wang J,
    2. Hassett JM,
    3. Dayton MT and
    4. Kulaylat MN
    : The prognostic superiority of log odds of positive lymph nodes in stage III colon cancer. J Gastrointest Surg 12(10): 1790-1796, 2008. PMID: 18709510. DOI: 10.1007/s11605-008-0651-3
    OpenUrlCrossRefPubMed
  7. ↵
    1. Persiani R,
    2. Cananzi FC,
    3. Biondi A,
    4. Paliani G,
    5. Tufo A,
    6. Ferrara F,
    7. Vigorita V and
    8. D’Ugo D
    : Log odds of positive lymph nodes in colon cancer: a meaningful ratio-based lymph node classification system. World J Surg 36(3): 667-674, 2012. PMID: 22270984. DOI: 10.1007/s00268-011-1415-x
    OpenUrlCrossRefPubMed
  8. ↵
    1. Tang R,
    2. Wang JY,
    3. Chen JS,
    4. Chang-Chien CR,
    5. Tang S,
    6. Lin SE,
    7. You YT,
    8. Hsu KC,
    9. Ho YS and
    10. Fan HA
    : Survival impact of lymph node metastasis in TNM stage III carcinoma of the colon and rectum. J Am Coll Surg 180(6): 705-712, 1995. PMID: 7773484.
    OpenUrlPubMed
  9. ↵
    1. Wang X,
    2. Hershman DL,
    3. Abrams JA,
    4. Feingold D,
    5. Grann VR,
    6. Jacobson JS and
    7. Neugut AI
    : Predictors of survival after hepatic resection among patients with colorectal liver metastasis. Br J Cancer 97(12): 1606-1612, 2007. PMID: 18071347. DOI: 10.1038/sj.bjc.6604093
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Anticancer Research: 42 (4)
Anticancer Research
Vol. 42, Issue 4
April 2022
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Prognostic Impact of N2 of the Primary Tumour in Surgical Resection for Colorectal Liver Metastases
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 8 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Prognostic Impact of N2 of the Primary Tumour in Surgical Resection for Colorectal Liver Metastases
KOICHI TOMITA, NAOKAZU CHIBA, SHIGETO OCHIAI, TAKAHIRO GUNJI, TOSHIMICHI KOBAYASHI, TORU SANO, EIJI HIDAKA, SHIGEYUKI KAWACHI
Anticancer Research Apr 2022, 42 (4) 1997-2001; DOI: 10.21873/anticanres.15678

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Prognostic Impact of N2 of the Primary Tumour in Surgical Resection for Colorectal Liver Metastases
KOICHI TOMITA, NAOKAZU CHIBA, SHIGETO OCHIAI, TAKAHIRO GUNJI, TOSHIMICHI KOBAYASHI, TORU SANO, EIJI HIDAKA, SHIGEYUKI KAWACHI
Anticancer Research Apr 2022, 42 (4) 1997-2001; DOI: 10.21873/anticanres.15678
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Conclusion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Comparison of BRCA2 Single Nucleotide Variants Between Japanese Patients With Familial Prostate Cancer, Sporadic Prostate Cancer, and Benign Prostatic Hyperplasia
  • Corrigendum
  • Sex-related Survival Differences in Patients With Glioblastoma – Results From a Retrospective Analysis
Show more Clinical Studies

Similar Articles

Keywords

  • colorectal liver metastasis
  • prognostic factor
  • lymph node metastasis
  • N factor
  • TNM classification
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire